title: Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
abstract: Polymerized fibrin strongly enhances tissue plasminogen activator (tPA)-mediated plasminogen activation, concomitant with exposure of 'fibrin-specific' epitopes at 'Aalpha148-160' and 'gamma312-324'. To investigate which aspects of polymerization are involved in these activities, we explored the fibrin polymerization process by evaluating the ability of factor XIIIa-crosslinked fibrinogen polymers to expose 'fibrin-specific' epitopes and enhance plasminogen activation. Crosslinked normal fibrinogen, fibrinogen with deficient [des Bbeta1-42] or defective [Birmingham (AalphaR16H)] fibrin 'D:E' assembly sites ('E(A)'), or with defective end-to-end self-association sites ('D:D') [Cedar Rapids (gammaR275C)], exposed both 'fibrin-specific' epitopes and enhanced tPA-dependent plasminogen activation, whereas non-crosslinked fibrinogens showed minimal or no such activities. Epitope expression in crosslinked fibrinogen was retained in the presence of the fibrin E(A) site peptide homolog, gly-pro-arg-pro (GPRP), which inhibits fibrin D:E association, except for the Aalpha148-160 epitope in des Bbeta1-42 fibrinogen, which was not expressed. Fibrin prepared from crosslinked normal or abnormal fibrinogen, except for the des Bbeta1-42 fibrin epitopes, which were reduced or absent, expressed 'fibrin-specific' epitopes even in the presence of GPRP, which otherwise impairs such expression in non-crosslinked fibrin. Epitope exposure in fibrin prepared from non-crosslinked fibrinogen was nearly normal in Cedar Rapids fibrin (heterozygous D:D defect), but reduced in Birmingham fibrin (heterozygous E(A) defect), nil in des Bbeta1-42 fibrin (E(A) deficient), and absent in all cases in the presence of GPRP. In contrast, plasminogen activation stimulatory activity that had been exposed in crosslinked normal fibrinogen or in crosslinked des Bbeta1-42 or Cedar Rapids fibrin, was preserved to a large extent in the presence of GPRP, suggesting that once enhanced stimulatory activity and epitopes are exposed, they are not completely reversible. The findings indicate that end-to-end intermolecular associations (D:D) are not critical for 'fibrin-specific' epitope exposure, but that polymerization brought about in fibrinogen through factor XIIIa crosslinking, or in fibrin through 'D:E' interactions, is necessary for 'fibrin-specific' (more correctly, 'polymerization-specific') epitope exposure and enhancement of plasminogen activation.
authors.affiliation: Sinai Samaritan Medical Center, University of Wisconsin Medical School-Milwaukee Clinical Campus, 53233, USA.
authors.forename: M W
authors.initials: MW
authors.lastname: Mosesson
authors.forename: K R
authors.initials: KR
authors.lastname: Siebenlist
authors.forename: M
authors.initials: M
authors.lastname: Voskuilen
authors.forename: W
authors.initials: W
authors.lastname: Nieuwenhuizen
mesh_terms: D000347:Afibrinogenemia / Q000097:blood; D004789:Enzyme Activation; D000939:Epitopes / Q000737:chemistry; D005176:Factor XIII / Q000378:metabolism; D005337:Fibrin / Q000737:chemistry / Q000502:physiology*; D005340:Fibrinogen / Q000737:chemistry / Q000378:metabolism; D005341:Fibrinolysin / Q000096:biosynthesis*; D006801:Humans; D046911:Macromolecular Substances; D010958:Plasminogen / Q000737:chemistry / Q000378:metabolism*; D011487:Protein Conformation; D017384:Sequence Deletion; D013329:Structure-Activity Relationship; D010959:Tissue Plasminogen Activator / Q000494:pharmacology
chemical_list: D000939:Epitopes; D046911:Macromolecular Substances; D005337:Fibrin; D005340:Fibrinogen; D010958:Plasminogen; D005176:Factor XIII; D010959:Tissue Plasminogen Activator; D005341:Fibrinolysin